VX-659

VX-659 · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VX-659, covering 2019-10-17 to 2022-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy [Phase 3]